ArticleBMC pharmacology & toxicology2025
Multifaceted anticancer activity of nafamostat mesylate in human fibrosarcoma: first evidence of mitochondrial apoptosis and suppressed MMP-2/-9 mRNA expression.
Cafer Yildirim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.